Media Library
-
ImagelockManufacturing / Image
Farmer Harvesting Artemisia Annua
In China, Novartis works with about 100,000 farmers who cultivate Artemisia annua, a crucial plant in the production of our antimalarial treatment. -
ImagelockManufacturing / Image
Artemisinin Extraction
We source our antimalarial treatment’s active pharmaceutical ingredients from China. Once the farming is done, the technical process begins. After the artemisinin has been extracted from the leaves, it is again dissolved in ethanol and processed for higher purity and quality. Here, a facility for the processing of artemisinin. -
ImagelockImage
Artemisinin-Combination Therapy (ACT)
Deliveries of this child-friendly antimalarial hit the 300 million mark. This child-friendly ACT is the first WHO prequalified child-friendly artemisinin-combination therapy (ACT). -
ImagelockManufacturing / Image
Antimalarial Raw Material
Antimalarial raw material before it is made into pills. -
ImagelockManufacturing / Image
Antimalarial Pills
Antimalarial pills before being packed -
ImagelockLeadership / Image
Harry Kirsch
Chief Financial Officer Member of the Executive Committee -
ImagelockLocations / Image
Trees casting shadows along Fabrikstrasse
-
ImagelockLeadership / Image
Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer (CEO) -
ImagelockLeadership / Image
Nancy C. Andrews, M.D., Ph.D.
Board member since 2015 -
ImagelockLeadership / Image
Ton Buechner
Board member since 2016 -
ImagelockLeadership / Image
Elizabeth (Liz) Doherty
Board member since 2016 -
ImagelockLeadership / Image
Charlotte Pamer-Wieser, Ph.D.
Corporate Secretary since 2011
Pagination
- ‹ Previous page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- › Next page